Nature to Independent 'Object/s' The Mutability of Biotechnology Patents: From Unwieldy Products of

[1]  B. Joerges.  Do Politics Have Artefacts? , 1999 .

[2]  Marianne de Laet,et al.  The Zimbabwe Bush Pump , 2000 .

[3]  A. Mol.  The Body Multiple: Ontology in Medical Practice , 2003 .

[4]  T. Kuhn,et al.  The Structure of Scientific Revolutions , 1963 .

[5]  Nick Lee,et al.  Otherness and the Actor Network , 1994 .

[6]  R. Nozick,et al.  Anarchy, State, and Utopia , 1978 .

[7]  Sheila Jasanoff,et al.  Technologies of Humility: Citizen Participation in Governing Science , 2003 .

[8]  L. Winner.  The Whale and the Reactor , 2020 .

[9]  John Law,et al.  Globalisation in practice: On the politics of boiling pigswill , 2008 .

[10]  John Law,et al.  Objects and Spaces , 2002 .

[11]  Rachel Schurman,et al.  Fighting “Frankenfoods”: Industry Opportunity Structures and the Efficacy of the Anti-Biotech Movement in Western Europe , 2004 .

[12]  B. Latour.  We Have Never Been Modern , 1991 .

[13]  Marc Berg,et al.  Differences in Medicine: Unraveling Practices, Techniques, and Bodies , 1999 .

[14]  M. Biagioli.  Patent Republic: Representing Inventions, Constructing Rights and Authors , 2006 .

[15]  G. Zweiger.  Transducing the Genome: Information, Anarchy, and Revolution in the Biomedical Sciences , 2001 .

[16]  D. Kevles.  A history of patenting life in the United States with comparative attention to Europe and Canada: a report to the European Group on Ethics in Science and New Technologies , 2002 .

[17]  M. Carolan.  From patent law to regulation: the ontological gerrymandering of biotechnology , 2008 .

[18]  M. Mulkay.  Norms and ideology in science , 1976 .

[19]  Rebecca S. Eisenberg,et al.  How Can You Patent Genes? , 2002, The American journal of bioethics : AJOB.

[20]  S. Prudham.  The Fictions of Autonomous Invention: Accumulation by Dispossession, Commodification and Life Patents in Canada , 2007 .

[21]  F. Buttel.  The Environmental and Post-Environmental Politics of Genetically Modified Crops and Foods , 2005 .

[22]  Lori B. Andrews,et al.  Genes and patent policy: rethinking intellectual property rights , 2002, Nature Reviews Genetics.

[23]  Steve Woolgar,et al.  Do Artefacts Have Ambivalence , 1999 .

[24]  Brian Wynne,et al.  Reflexing Complexity , 2005 .

[25]  K. Bakker.  The “Commons” Versus the “Commodity”: Alter‐globalization, Anti‐privatization and the Human Right to Water in the Global South , 2007 .

[26]  S. Jasanoff.  Contested Boundaries in Policy-Relevant Science , 1987 .

[27]  Opposite Thermodynamic Arrows of Time , 1999, cond-mat/9911101.

[28]  T. Gieryn.  Boundary-work and the demarcation of science from non-science: Strains and interests in professional , 1983 .

[29]  R. Eisenberg,et al.  Re-examining the role of patents in appropriating the value of DNA sequences. , 2000, Emory law journal.

[30]  S. Benowitz.  French challenge to BRCA1 patent underlies European discontent. , 2002, Journal of the National Cancer Institute.

[31]  Rebecca S. Eisenberg,et al.  Patents and data-sharing in public science , 2006 .

[32]  M. Strathern.  Cutting the Network , 1996 .

[33]  M. Walzer.  I. Liberalism and the Art of Separation , 1984 .

[34]  J J Doll,et al.  The Patenting of DNA , 1998, Science.